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Résumé en
anglais
Objective: To determine whether treatment with memantine plus vitamin D is more
effective than memantine or vitamin D alone in improving cognition among patients
with Alzheimer disease (AD). Methods: We studied 43 white outpatients (mean
84.7±6.3 years; 65.1% women) with a new diagnosis of AD, who had not taken anti-
dementia drugs or vitamin D supplements. We prescribed memantine alone (n=18),
vitamin D alone (n=17), or memantine plus vitamin D (n=8) for an average of 6
months. We assessed cognitive change with the Mini-Mental State Examination
(MMSE). We used age, sex, pre-treatment MMSE score, and duration of treatment as
covariables. Results: Before treatment, the 3 groups had comparable MMSE scores. At
6 months, participants taking memantine plus vitamin D increased their MMSE score
by 4.0±3.7 points (P=0.034), while participants taking memantine alone remained
stable (change of 0.0±1.8 points; P=0.891), as did those taking vitamin D alone
(−0.6±3.1 points; P=0.504). Treatment with memantine plus vitamin D was associated
with improvement in the MMSE score compared to memantine or vitamin D alone after
adjustment for covariables (P<0.01). Mixed regression analysis showed that the visit
by combined treatments (memantine plus vitamin D) interaction was significant
(P=0.001), while memantine or vitamin D alone showed no effect. Conclusions:
Patients with AD who took memantine plus vitamin D for 6 months had a statistically
and clinically relevant gain in cognition, underlining possible synergistic and
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